MedTrace Logo

GLycaemic Outcomes With Whey Protein in ageING

NCT07285811 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2025-12-16

No results posted yet for this study

Summary

The goal of this placebo-controlled, partial crossover design study is to identify the impact of consuming whey protein before meals on free-living glucose control in older adults living with type 2 diabetes.

The primary specific objective is to determine the effect of a thrice daily whey protein pre-meal supplementation at two doses, on glucose excursions over a 7-day free-living period in adults aged 75-90 years of age, living with type 2 diabetes, compared with a non-protein placebo.

Participants will consume the whey protein and placebo for 7 days each, before each meal. All participants will consume the placebo and one of two doses of whey protein, in a randomised order.

Conditions

Interventions

DIETARY_SUPPLEMENT

Glycaemic control with whey protein

Comparing pre-meal supplementation of whey protein to protein-free placebo.

DIETARY_SUPPLEMENT

Glycaemic control with different doses of whey protein

Comparing pre-meal supplementation of moderate whey protein to a low dose of whey protein.

Sponsors & Collaborators

  • Newcastle University

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Leigh Breen, PhD · University of Birmingham and University of Leciester

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
75 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-31
Primary Completion
2026-08-31
Completion
2026-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07285811 on ClinicalTrials.gov